Biosyent Inc (RX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 35,031 | 31,590 | 27,925 | 28,618 | 22,332 |
| Cost of Goods | 7,175 | 5,992 | 5,067 | 5,980 | 4,908 |
| Gross Profit | 27,856 | 25,598 | 22,858 | 22,638 | 17,424 |
| Operating Expenses | 18,792 | 18,064 | 15,951 | 14,390 | 12,298 |
| Operating Income | 9,064 | 7,534 | 6,907 | 8,248 | 5,126 |
| Interest Expense | 59 | 68 | 77 | 85 | 93 |
| Other Income | 777 | 1,068 | 601 | 216 | 204 |
| Pre-tax Income | 9,782 | 8,534 | 7,431 | 8,378 | 5,237 |
| Income Tax | 2,512 | 2,074 | 1,972 | 2,097 | 1,442 |
| Net Income Continuous | 7,270 | 6,460 | 5,458 | 6,282 | 3,795 |
| Net Income | $7,270 | $6,460 | $5,458 | $6,282 | $3,795 |
| EPS Basic Total Ops | 0.63 | 0.54 | 0.44 | 0.50 | 0.29 |
| EPS Basic Continuous Ops | 0.63 | 0.54 | 0.44 | 0.50 | 0.29 |
| EPS Diluted Total Ops | 0.62 | 0.53 | 0.44 | 0.49 | 0.29 |
| EPS Diluted Continuous Ops | 0.62 | 0.53 | 0.44 | 0.49 | 0.29 |
| EBITDA(a) | $10,432 | $9,058 | $7,959 | $8,921 | $5,840 |